Articles

Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

Santos RD, Ruzza A, Hovingh GK, et al.

First published: October 1, 2022  DOI: 10.1016/S2213-8587(22)00221-2